Testing for biomarkers, such as mutations in epidermal growth factor receptor (EGFR), is an important step in determining treatment options for patients with lung cancer, and the process can begin at medical oncology practices like yours. Our goal is to offer resources that help you navigate the testing process and become an expert at your practice.
This website has been developed in collaboration with HCPs to provide educational resources about testing for EGFR mutations in patients with metastatic non–small cell lung cancer (NSCLC), both at the time of initial diagnosis and at disease progression.
You can learn about the biomarker testing process and become a valued Diagnostic Navigator in your office.
What you can do with EGFR Diagnostic Navigator